MUTUAL TERMINATION AGREEMENTMutual Termination Agreement • March 22nd, 2024 • Checkpoint Therapeutics, Inc. • Pharmaceutical preparations
This Mutual Termination Agreement (this “Agreement”) is effective as of September 30, 2023 (the “Effective Date”) by and between Checkpoint Therapeutics, Inc., a Delaware corporation with its place of business at 95 Sawyer Road, Suite 110, Waltham, MA 02453 (“CTI”) and TG Therapeutics, Inc., a Delaware corporation with its place of business at 2 Gansevoort Street, 9th Floor, New York, New York 10014 (“TGTX”). CTI and TGTX may each individually be referred to as a “Party” herein and collectively as the “Parties.”
MUTUAL TERMINATION AGREEMENTMutual Termination Agreement • March 22nd, 2024 • Checkpoint Therapeutics, Inc. • Pharmaceutical preparations
This Mutual Termination Agreement (this “Agreement”) is effective as of September 30, 2023 (the “Effective Date”) by and between Checkpoint Therapeutics, Inc., a Delaware corporation with its place of business at 95 Sawyer Road, Suite 110, Waltham, MA 02453 (“Checkpoint”) and TG Therapeutics, Inc., a Delaware corporation with its place of business at 2 Gansevoort Street, 9th Floor, New York, New York 10014 (“TGTX”). Checkpoint and TGTX may each individually be referred to as a “Party” herein and collectively as the “Parties”.
